Other official information and services: www.belgium.be  belgium

Anticholinergics (65 years and older)

  • Key figures
  •  Data
  • Graphics
  • Comments
PRESCRIBERS
Main prescribers: General practitioners 85.06%
INSURED CONSUMERS
% of insured consumers 17.74%
Median age 75 years
Max/min ratio of the median age (by district) 1.04
Percentage of women 65.84%
Ratio Preferential scheme/General scheme 1.56
Coefficient of variation (2022) 12.09
Max/min ratio of % of insured consumers (by district) 1.57
CONSUMPTION
Annual consumption (DDD) 132,829,888
Consumption of DDD (per 100,000 insured persons) 5,563,569.51
% DDD issued outside the insurance (approximate) 39.42%
Average annual consumption per insured consumer (DDD) 313.69
% of insured consumers with > 3 times the average consumption 2,80%
Coefficient of variation 2020-2022 13.04
Coefficient of variation 2020-2022 13.04
Trend 2020-2022 -0.26%
Trend 2020-2020 NA
Trend 2020-2022 NA
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance 41,552,314€
Average annual expenditure per insured person 17.40 €
Average patient share per insured consumer 21.33%
Max/min ratio of expenditure per insured person (by disctrict) 1.57
% “Low-cost” medication 85.53%
Trend 2020-2022 -1.96%
Trend 2020-2022 NA


On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES (ATC-5) LABELS
A02BA H2-RECEPTOR ANTAGONISTS
A03FA PROPULSIVES
A07DA ANTIPROPULSIVES
G04BD URINARY ANTISPASMODICS
G04BE DRUGS USED IN ERECTILE DYSFUNCTION
M03BX OTHER CENTRALLY ACTING AGENTS
N02AA NATURAL OPIUM ALKALOIDS
N02AB PHENYLPIPERIDINE DERIVATIVES
N02AX OTHER OPIOIDS
N03AE BENZODIAZEPINE DERIVATIVES
N03AF CARBOXAMIDE DERIVATIVES
N04AA TERTIARY AMINES
N04BB ADAMANTANE DERIVATIVES
N05AA PHENOTHIAZINES WITH ALIPHATIC SIDE-CHAIN
N05AD BUTYROPHENONE DERIVATIVES
N05AH DIAZEPINES, OXAZEPINES, THIAZEPINES AND OXEPINES
N05AX OTHER ANTIPSYCHOTICS
N05BA BENZODIAZEPINE DERIVATIVES
N05BB DIPHENYLMETHANE DERIVATIVES
N05CD BENZODIAZEPINE DERIVATIVES
N06AA NON-SELECTIVE MONOAMINE REUPTAKE INHIBITORS
N06AB SELECTIVE SEROTONIN REUPTAKE INHIBITORS
N06AX OTHER ANTIDEPRESSANTS
R03AL ADRENERGICS IN COMBINATION WITH ANTICHOLINERGICS
R03BB ANTICHOLINERGICS
R03DA XANTHINES
R05DA OPIUM ALKALOIDS AND DERIVATIVES
R06AA AMINOALKYL ETHERS
R06AD PHENOTHIAZINE DERIVATIVES
R06AE PIPERAZINE DERIVATIVES

The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Click below to see the graph illustrating the evolution of the breakdown by volume of ATC codes used for the rates.

Anticholinergics (65 years and older) (2022)

+ - Population selection Click to collapse

Older than or equal to 65 years

Min 80 ddd per drug per year

+ - Analysis period Click to collapse

2022

  • ATC codesATC codes
  • Age Sex CVAge, sex and CV
  • Rates by sexRates by sex
  • Reimbursement rateReimbursement rate
  • TrendsTrends by region
  • Trends breakTrends break
  • Dot PlotDot Plot
  • Funnel PlotFunnel plot
  • Provincial consumptionDDD per patient by province
  • DDD patientQuantity per patient
  • MapDistribution map
  • Low-costLow-cost DDD

WE ARE INTERESTED IN YOUR OPINION

Do you have any experience in this area ? We listen to you !

Send us an email

   Download the full report
 Download the methodology